Areva Med LLC Report issue

For profit Phase 1
Founded: Paris France (2001)
Status: Defunct (2016)

Organization Overview

First Clinical Trial
2011
NCT01384253
First Marketed Drug
2008
pamidronate (aredia)
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

AREVA PHARMS

Active Ingredients

Marketed Drugs (4)

fludarabine (fludara) (2010)

furosemide (lasix) (2020)

pamidronate (aredia) (2008)

verapamil (calan) (2020)

Drugs in Phase 1 Trials (1)

trastuzumab (herceptin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 1)

Neoplasms (Phase 1)

Ovarian Neoplasms (Phase 1)

Pancreatic Neoplasms (Phase 1)

Peritoneal Neoplasms (Phase 1)

Stomach Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1